PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Mol Microbiol. Author manuscript; available in PMC 2013 August 1.
Published in final edited form as:
PMCID: PMC3418420
NIHMSID: NIHMS383715

RecA mediates MgpB and MgpC phase and antigenic variation in Mycoplasma genitalium, but plays a minor role in DNA repair

Summary

Mycoplasma genitalium, a sexually transmitted human pathogen, encodes MgpB and MgpC adhesins that undergo phase and antigenic variation through recombination with archived “MgPar” donor sequences. The mechanism and molecular factors required for this genetic variation are poorly understood. In this study, we estimate that sequence variation at the mgpB/C locus occurs in vitro at a frequency of >1.25 × 10−4 events/ genome/generation using a quantitative anchored-PCR assay. This rate was dramatically reduced in a recA deletion mutant and increased in a complemented strain overexpressing RecA. Similarly, the frequency of hemadsorption-deficient phase variants was reduced in the recA mutant, but restored by complementation. Unlike Escherichia coli, inactivation of recA in M. genitalium had a minimal effect on survival after exposure to mitomycin C or UV irradiation. In contrast, a deletion mutant for the predicted nucleotide excision repair (NER) uvrC gene, showed growth defects and was exquisitely sensitive to DNA damage. We conclude that M. genitalium RecA has a primary role in mgpB/C-MgPar recombination leading to antigenic and phase variation, yet plays a minor role in DNA repair. Our results also suggest that M. genitalium possess an active NER system, possibly representing the main DNA repair pathway in this minimal bacterium.

Keywords: mycoplasma, RecA, antigenic variation, phase variation, DNA repair, nucleotide excision repair

Introduction

Mycoplasma genitalium is an emerging sexually transmitted pathogen associated with acute and chronic urethritis in men (Jensen, 2004), and cervicitis, endometritis, pelvic inflammatory disease and tubal factor infertility in women (Manhart et al., 2003; Cohen et al., 2002; Haggerty, 2008). When untreated or inappropriately treated, M. genitalium persists for months or even years (Cohen et al., 2007; Iverson-Cabral et al., 2006), potentially increasing the risk for sexual transmission and serious upper reproductive tract infection. Besides its importance as a pathogen, M. genitalium has the smallest genome (580 kb, encoding 482 predicted proteins) described so far for an organism capable of self-replication (Fraser et al., 1995), and thus has served as a model organism to study the minimal requirements to sustain life (Glass et al., 2006; Carvalho et al., 2005).

The molecular basis of M. genitalium pathogenesis and the mechanisms responsible for persistence are poorly understood, yet are thought to be linked in part to its complex terminal organelle. This distinctive structure mediates adherence, motility and cell division (Burgos et al., 2006; Burgos et al., 2007; Lluch-Senar et al., 2010) and is composed of a complex array of unique proteins (Krause and Balish, 2004). Among these proteins are MgpB (also referred as P140, MgPa or MG_191) and MgpC (also referred as P110 or MG_192), two surface exposed proteins essential for cell adhesion and terminal organelle development (Burgos et al., 2006). Although MgpB and MgpC are encoded in a single expression site located at the MgPa operon, certain segments of the mgpB and mgpC genes (referred herein as mgpB/C) are found in multiple copies throughout the genome (Iverson-Cabral et al., 2007; Iverson-Cabral et al., 2006; Ma et al., 2007). These partial copies are known as mgpB repeat regions B, EF and G, and mgpC repeat region KLM, and are organized in nine distinct chromosomal locations termed MgPa repeats (MgPars 1 to 9). Overall, the MgPars are 78–90% identical to the corresponding sequences within the expression site and represent 4% of the reduced genome (Fraser et al., 1995). These observations prompted the hypothesis that recombination between sequences in the mgpB/C expression site and the MgPars could mediate MgpB and MgpC antigenic variation (Peterson et al., 1995). In addition, the distribution and architecture of the repetitive sequences within the MgPar sites also provides a mechanism to promote deletions in the mgpB/C genes, thus also contributing to MgpB/C phase variation (Burgos et al., 2006). The observation that, MgpB and MgpC are among the most immunogenic proteins of M. genitalium (Svenstrup et al., 2006; Iverson-Cabral et al., 2011), sustains the notion that antigenic variation in these proteins may enable this microorganism to evade the immune response and establish persistent infections. In support of this hypothesis, we and others have demonstrated that sequence heterogeneity of mgpB/C is extensive in vitro and in vivo (Iverson-Cabral et al., 2006; Ma et al., 2007) and evolves over time in persistently infected women (Iverson-Cabral et al., 2007).

The isolation and characterization of mgpB/C clonal variants revealed that mgpB/C gene diversity is achieved through segmental and reciprocal recombination with the MgPars (Iverson-Cabral et al., 2007). Of note, this mechanism differs from other known antigenic variation systems based on DNA recombination, which are generally characterized by unidirectional gene conversion events (Vink et al., 2011). Although the specific molecular factors and mechanisms underlying mgpB/C gene variation are not known, the outcome of this diversity suggests that the general recombination apparatus of M. genitalium could be involved. However, genome sequence analysis revealed that many of the genes typically involved in bacterial recombination and DNA repair are apparently absent in this organism (Carvalho et al., 2005). Particularly intriguing is the apparent lack of genes involved in the initiation step of recombination, such as recFOR, recBCD or addAB (Rocha et al., 2005). Thus, how recombination events are initiated remains enigmatic and suggests that additional and novel factors may be required to elicit and possibly regulate the mgpB/C recombination. Nevertheless, the M. genitalium genome contains genes encoding homologs of the basic recombination enzymes required to promote strand exchange, branch migration and resolution of the Holliday junction, all of which are essential steps in recombination (Kowalczykowski et al., 1994). Among these genes are MG_339 which encodes a RecA homolog exhibiting DNA strand exchange activity in vitro (Sluijter et al., 2009), MG_358 and MG_359 which encode homologs for the RuvA and RuvB branch migration proteins (Estevao et al., 2011), and MG_352 which encodes a RecU homolog displaying Holliday junction resolving activity on synthetic substrates (Sluijter et al., 2010). Although the in vitro activities of these proteins have been recently analyzed (Vink et al., 2011), no genetic study elucidating the enzymatic machinery required to promote mgpB/C diversity in M. genitalium cells has been reported.

In the present study, we examined the role of the MG_339 (recA) gene of M. genitalium on mgpB/C-MgPar recombination and DNA repair. We demonstrate that RecA is required to promote sequence diversity at the mgpB/C locus. Similarly, we show that hemadsorption-deficient phase variants arise predominantly by a RecA-dependent mechanism, consistent with MgpB/C phase variation mediated by mgpB/C-MgPar recombination (Burgos et al., 2006). In contrast to other bacterial species, we also show that RecA has a minor role in DNA repair, whereas nucleotide excision repair (NER) could be the main DNA repair pathway in M. genitalium.

Results

Construction of a M. genitalium recA null mutant

The M. genitalium RecA protein is encoded at the MG_339 locus, which is flanked by the MG_338 gene (putatively encoding a lipoprotein) and the MgPa repeat region 9 (Fig. 1A). To investigate the function of RecA in M. genitalium, we constructed a recA null mutant by gene replacement. For this purpose, we produced the suicide plasmid pΔMG_339, which contains the chloramphenicol resistance gene inserted into regions flanking the MG_339 locus. A double crossover event between plasmid pΔMG_339 and the mycoplasma genome replaces bases 427113 to 430580 by the antibiotic marker (base coordinates refer to GenBank accession number NC_000908). The resulting 3469 bp deletion includes the full length recA open reading frame except for the 3′-terminal 23 bp (deletion of the 97.7% coding sequence), and the entire MgPar 9 (Fig. 1A). The intended deletion was confirmed by PCR amplification with selected primers (Fig. 1B) and Southern blot analyses (Fig. S1). To our knowledge, this is the first report of the successful use of the chloramphenicol resistance gene to genetically modify M. genitalium, thus expanding the selective markers available for this microorganism (Pich et al., 2006b; Algire et al., 2009).

Fig. 1
Gene replacement at the MG_339 locus

The absence of M. genitalium RecA protein in the mutant was further demonstrated by immunoblot analyses using polyclonal antibodies raised against M. genitalium RecA (Fig. 1C). Interestingly, we found that these antibodies recognized two main bands on immunoblots of wild-type cell lysates (Fig. 1C), even though the protein is encoded by a single gene. One of these bands migrated slightly below the predicted molecular size of 37.4 kDa, whereas the second band was approximately 34 kDa. A third faint band that migrated slightly higher than the 34 kDa band was also observed. Remarkably, these bands were absent in the ΔrecA mutant and were restored upon complementation, thus confirming their RecA origin (Fig. 1C). To further demonstrate the specificity of our antibodies recognizing M. genitalium RecA species, we analyzed M. genitalium and E. coli cell lysates expressing His-tagged and non-tagged RecA variants (Fig. S2). Interestingly, only the slow migrating band of ~37 kDa was detected when M. genitalium RecA protein was expressed in E. coli (Fig. S2D). In contrast, when we analyzed cell lysates of a M. genitalium ΔrecA mutant expressing a His-tagged RecA derivative, we detected the three RecA protein species with the expected shift in their electrophoretic mobility (Fig. S2C). Taken together, these results suggest that M. genitalium expresses several isoforms of RecA, although further studies are needed to confirm this hypothesis.

Frequency and rate of mgpB/C gene variation

Several studies have demonstrated that variation within the mgpB/C expression site is a result of recombination with the MgPars (Iverson-Cabral et al., 2007; Ma et al., 2007; Iverson-Cabral et al., 2006), yet the frequency of these events is not known. To address this question, we developed several qPCR-based assays to estimate the frequency of selected mgpB/C variants in a given population. As depicted in Figure 2A, this assay is based on the use of a pair of primers, one targeting a conserved region in the mgpB/C expression site, the other targeting a unique sequence in one or multiple MgPars, resulting in a PCR product only when the targeted sequence from an MgPar is translocated into the expression site (generating an mgpB/C variant). Thus, when the resulting products are quantified by real-time PCR and normalized to the number of genomes used in the assay, we can estimate the frequency of variants containing the targeted MgPar sequences within the population. Based on this strategy, we designed four different anchored qPCRs, designated B-24, EF-2478, G-135 and KLM-7 (see Experimental procedures). In combination, these qPCR assays detect variants spanning all four of the variable regions (B, EF, G and KLM) and almost all MgPar sites (except MgPar 9 and the small MgPar 6 site) (Iverson-Cabral et al., 2007).

Fig. 2
Gene variation at the mgpB/C locus

Using these qPCR assays, we found that the frequency of variants detected per genome in our M. genitalium clone G37C (see Experimental procedures) after two passages (7 generations each) was 2.1 × 10−4, 3.4 × 10−4, 9.1 × 10−4 and 1.6 × 10−3, for KLM-7, B-24, G-135 and EF-2478, respectively (Fig. 2C–F and Fig. S3). In these experiments, the number of variants detected is well correlated with the number of donor sites targeted by each anchored PCR. Specifically, the frequency of variants for B-24, G-135 and EF-2478 which target respectively, 2, 3 and 4 MgPars, was 1.6, 4.3 and 7.6 times greater than that of KLM-7 which targets a single MgPar. Furthermore, the anchored PCR products showed a variety of sequence variants consistent with the occurrence of different recombination events between mgpB/C and the targeted MgPar sites (data not shown). Importantly, the frequency of variants detected increased over time, demonstrating that new variants arise during in vitro propagation (Fig. 2C–F and Fig. S3). Consequently, we also estimated the spontaneous recombination rate in vitro, by measuring the change in frequency every two passages for a propagation period of 10 passages. The calculated rates of gene variation for each qPCR assay, after normalizing by the estimated number of generations, are shown in Table 1. These results indicate that all the variable regions constantly undergo sequence diversity. After normalizing all the qPCR assays to one donor site, we estimated that the average recombination rate in a single variable region was 4.48 (± 2.1) × 10−6 events per genome per generation. Since there are four variable regions (B, EF, G, and KLM) in mgpB/C, each represented in 5 to 8 copies in the MgPars (Iverson-Cabral et al., 2007), we estimate that there are a minimum of 28 possible recombination events, assuming a single recombination event per variable region and possible donor site. Therefore, if all variable regions recombine at a similar rate and taking this minimum number of possible exchange combinations, we hypothesize that mgpB/C gene variation occurs at rates higher than 1.25 × 10−4 events per genome per generation. These results suggest that the potential to generate gene diversity in M. genitalium is high and could be similar to other well characterized systems of bacterial antigenic variation (Criss et al., 2005; Helm and Seifert, 2010; Turner and Barry, 1989).

Table 1
Recombination rates at the mgpB/C locus in G37C, ΔrecA and ΔrecA+recA strains.

M. genitalium RecA is required for mgpB/C gene variation

To investigate the role of RecA in mgpB/C gene variation, we determined the occurrence of mgpB/C variants in the ΔrecA mutant. By applying the qPCR-based assay we found that loss of RecA drastically reduced the frequency of mgpB/C variants, although a few recombinants were still detected (ranging from 2.6 × 10−5 KLM-7 variants to 1.1 × 10−4 EF-2478 variants, Fig. 2C–F). Moreover, in the absence of RecA we were unable to see accumulation of variants during the ten passages of propagation (Table 1). To examine in more detail whether these variants detected in the ΔrecA mutant were genuine or PCR artifacts generated in the absence of recombinant template (Paabo et al., 1989), we adapted our anchored PCR assay to a nested PCR format as follows. We amplified the KLM variable region using primers targeting flanking conserved sequences in the mgpC gene, and used this PCR product as a template for the KLM-7 anchored PCR assay. Using this strategy, we still detected variants in the ΔrecA mutant (data not shown), reinforcing the idea that these recombinants were genuine.

Growth defects upon recA inactivation have been described for several bacteria (Sciochetti et al., 2001). To ensure that this potential phenotype did not impact the recombination rates, we also compared the growth curves of the wild-type and ΔrecA mutant. As shown in Figure 3, the growth characteristics of the ΔrecA mutant were comparable to that of the parental strain, with doubling times of approximately 17 hours.

Fig. 3
Growth curves of wild-type G37 and its derivatives strains, ΔrecA, ΔrecA+recA, ΔuvrC and ΔuvrC+uvrC. Growth was monitored over time by measuring the number of genomes by qPCR. Data is shown in a semi-logarithmic plot and ...

Reintroduction of a wild-type copy of the recA gene into the ΔrecA mutant restored the frequency of mgpB/C variants, and even increased the recombination rates for all the variable regions analyzed (Fig. 2C–F and Table 1). To examine if variations in expression of RecA could be the cause of this recombination enhancement, we compared the quantity of recA transcripts in the G37C and ΔrecA+recA strains by qRT-PCR. As shown in Figure 2B, the complemented mutant exhibited a ~2.5 fold increase in the expression levels of recA compared to the G37C strain. Southern blot analyses demonstrated that a single transposon was inserted in the genome of the ΔrecA+recA strain, ruling out the possibility that the increase in expression could be due to the presence of multiple copies of recA (Fig. S4). Alternatively, the genomic environment of the insertion site may explain the increase in the expression of the delivered recA gene. The transposon insertion was located at repeat region G of the MgPar 4. Importantly, this insertion does not disrupt coding regions, and does not affect any of the variable regions in MgPar 4 targeted by the anchored PCR assays (Fig. S4). Similar results were also obtained when we analyzed different ΔrecA+recA transformants also expressing increased levels of recA transcripts (data not shown). Taken together, these results demonstrate that RecA mediates mgpB/C gene diversity and suggest that variations in the RecA levels influence the rates of mgpB/C gene variation.

Generation of spontaneous non-adherent phase variants is dependent on RecA expression

It has been previously shown that M. genitalium hemadsorption-deficient (HA) variants arise spontaneously at high rates (Mernaugh et al., 1993). Further characterization of these variants revealed that they originated by deletions in mgpB and mgpC genes as a consequence of recombination events with the MgPar sites, suggesting a possible mechanism for MgpB/C phase variation (Burgos et al., 2006). These observations suggest that, in addition to promoting gene variation, RecA might also be required for the generation of non-adherent phase variants. To test this hypothesis, we examined the presence of HA variants in the G37C and ΔrecA strains. We found that the frequency of phase variants in G37C was 0.6% at passage 1 and increased to 5% after 10 passages (Fig. 4). In contrast, the ΔrecA mutant exhibited a frequency of 0.04% throughout the experiment. Complementation of the ΔrecA mutant restored its capacity to generate HA variants at a frequency that was 3 fold higher than G37C at passage 1, consistent with the previous finding of enhancement of mgpB/C gene variation (Fig. 2 and Table 1). After 10 passages, the ΔrecA+recA strain showed a similar frequency of HA variants as the G37C strain, likely indicating the achievement of equilibrium. These results demonstrate that HA phase variants are predominantly derived by a RecA-dependent mechanism.

Fig. 4
Role of RecA in generating hemadsorption-deficient (HA) phase variants

M. genitalium RecA protein plays a minor role in DNA repair

Given the central role that RecA plays in DNA repair in other organisms, we also examined the DNA repair capabilities of the M. genitalium ΔrecA mutant. First, we compared the sensitivity of wild-type and ΔrecA strains to DNA damage induced by UV light. Surprisingly, no differences were observed even at the highest dose (Fig. 5A). Subsequently, we tested the sensitivity to increasing levels of mitomycin C (MMC). This DNA-damaging agent causes DNA strand cross-links, resulting in single and double-strand breaks (DSBs), the latter requiring homologous recombination for repair. After 24 hours of treatment with increasing concentrations of MMC, we observed a progressive decrease in cell viability for both strains (Fig. 5B). Although the sensitivity exhibited by the ΔrecA mutant was greater than the parental strain at higher dosages, these differences were not statistically significant. Taken together, these results suggest that RecA plays a minor role in DNA repair in M. genitalium.

Fig. 5
Survival of wild-type G37, ΔrecA, ΔuvrC and ΔuvrC complemented strains after (A) UV irradiation and (B) mitomycin C (MMC) treatment. Survivals are shown in semi-logarithmic plots and represent the mean ± standard deviation ...

NER may be the major DNA repair pathway in M. genitalium

Nucleotide excision repair (NER) is an important mechanism that can repair UV-induced DNA damage and other bulky lesions. In E. coli NER is executed by the cooperative action of the encoded products of the uvrA, uvrB, uvrC and uvrD genes (Van Houten et al., 2005). Homologs of these genes have also been identified in the M. genitalium genome, representing the only complete DNA repair pathway identified in this genomically-limited pathogen (Carvalho et al., 2005). The minor role of RecA in DNA repair in M. genitalium led us to further characterize the DNA repair capabilities of this microorganism. To accomplish this, we constructed a null mutant of the MG_206 gene, which is predicted to encode a protein with 27% amino acid identity to E. coli UvrC. To do so, we constructed the suicide plasmid pΔMG_206, engineered to promote the replacement of 88.1% of the coding sequence of the MG_206 gene with the tetM438 antibiotic marker by homologous recombination (Fig. 6A). The intended allelic exchange was confirmed by PCR amplification with selected primers (Fig. 6B) and Southern blot analyses (Fig. S1).

Fig. 6
Gene replacement at the MG_206 locus

When propagating the ΔuvrC mutant we noticed that colonies were smaller compared to the wild-type strain (data not shown) and that the mutant also grew slower in liquid media. Comparison of the growth curves of the ΔuvrC mutant with the wild-type strain revealed a similar growth rate but a delay in the onset of the logarithmic phase (Fig. 3). This growth defect was partially complemented by the reintroduction of a wild-type uvrC copy (Fig. 3).

To test a possible role of UvrC in gene variation, we analyzed the frequency of mgpB/C variants in the ΔuvrC mutant, but no significant differences were observed when compared to G37C (data not shown). The ΔuvrC mutant was then tested for survival following DNA damage induced by UV irradiation and MMC. As expected, this mutant was extremely sensitive to UV light, exhibiting a ~104 fold decrease in survival relative to the wild-type strain at a UV dose of 10 J m−2 (Fig. 5A). Similarly, the ΔuvrC mutant also exhibited a greater sensitivity to MMC (Fig. 5B). For example, after treatment with 80 ng ml−1 of MMC, the viability of the wild-type strain and the ΔrecA mutant was respectively, 150- and 46-fold greater than that of the ΔuvrC mutant. Complementation of the ΔuvrC mutant with a wild-type copy of uvrC restored the UV and MMC survival to wild-type levels (Fig. 5). Indeed, an enhanced UV survival was observed in the complemented mutant strain (Fig. 5A), reinforcing the important role of NER pathway in repairing UV-induced damage. We conclude that M. genitalium has the capacity to repair its DNA and that the uvrC gene is critical to M. genitalium survival after DNA damage. These observations support the hypothesis that M. genitalium possess an active NER system, which could represent the main DNA repair pathway in this minimal bacterium.

Discussion

Phase and antigenic variation are common mechanisms employed by pathogenic bacteria to overcome immune pressure or to respond to different niches and environments between or within hosts (Henderson et al., 1999; van der Woude and Baumler, 2004). Mycoplasmas possess a number of sophisticated systems to diversify their surfaces, including switching of gene expression by DNA slippage or site-specific recombination events, or promoting antigenic variation by unidirectional gene conversion events as occurs with the VlhA protein of Mycoplasma synoviae (Citti et al., 2010). Despite its reduced genome, M. genitalium also undergoes phase and antigenic variation in two of its surface proteins (MgpB and MgpC), but accomplishes this by a unique mechanism based on reciprocal recombination events (Iverson-Cabral et al., 2007). To understand the mechanisms governing MgpB/C phase and antigenic variation, we defined the role of the M. genitalium RecA protein, a pivotal enzyme required for recombination and DNA repair in other organisms. We found that RecA is required for mgpB/C sequence diversity as well MgpB/C phase variation, yet plays a minor role in DNA repair in M. genitalium.

To undertake these studies, we developed an anchored qPCR-based assay that allows the straightforward determination of mgpB/C diversity within the population. Using this assay, we estimated that variation within mgpB/C genes occurs at rates of at least 1.25 × 10−4 events per genome per generation. This value is expected to be much higher, since our assay and rate estimates only consider a subset of the possible recombination events between the expression locus and donor sites. Therefore, to measure the full potential of mgpB/C gene variation, other unbiased approaches should be considered, such as those previously described based on large-scale DNA sequencing (Criss et al., 2005; Helm and Seifert, 2010). Regardless, our results suggest that M. genitalium may undergo gene variation at rates similar to that exhibited by other species having recombination-based antigenic variation systems. For example, Neisseria meningitidis and Neisseria gonorrhoeae exhibit rates of 1.6 × 10−3 and 4 × 10−3 events per cell per generation, respectively (Helm and Seifert, 2010; Criss et al., 2005). Trypanosoma brucei, an eukaryotic parasite transmitted through insect vectors, possesses a similar degree of sequence diversity (Turner and Barry, 1989), although switching rates are drastically reduced in laboratory-adapted strains (Turner, 1997).

Our anchored qPCR-based assay has proven to be particularly useful to compare mgpB/C gene variation between wild-type and mutant strains. Using this assay we have found that mgpB/C gene variation is drastically decreased in a ΔrecA mutant, demonstrating the involvement of RecA in mgpB/C diversity. Given the recombinatorial nature of the MgPar system, this result is not surprising, since RecA is the central player in homologous recombination, promoting genetic exchange by pairing homologous DNA substrates in an ATP-dependent fashion (Kuzminov, 1999; Sluijter et al., 2009). Similarly, antigenic variation systems from N. gonorrhoeae and T. brucei are also dependent respectively, on the action of RecA and Rad 51, the eukaryotic homologue of RecA (Koomey et al., 1987; McCulloch and Barry, 1999). However, a different scenario is found in Borrelia burgdorferi, in which the RuvAB helicase, but not RecA are required for vlsE antigenic variation (Dresser et al., 2009; Lin et al., 2009; Liveris et al., 2008). An intriguing observation of this study was that, despite the significant reduction in recombination rate, a small but detectable number of mgpB/C variants were still detected in the ΔrecA mutant. Therefore, although a RecA-dependent mechanism appears to be the main pathway, we cannot exclude the existence of an alternative mechanism to generate mgpB/C gene variation in M. genitalium. Of note, evidence for RecA-independent recombination events has been previously reported in E. coli (Dutra et al., 2007). Similarly, we also determined that spontaneous HA phase variants arise principally by a RecA-dependent mechanism, yet a limited number of HA variants were detected in the absence of RecA. These results are consistent with our previous work showing that HA variants (designated class I and class II mutants) were the result of large deletions affecting the MgpB/C locus, driven by recombination between the expression site and the MgPar sequences (Burgos et al., 2006). The origin of the few HA variants found in the recA background could be due to spontaneous point mutations in the mgpB/C locus or other cytadherence related genes. However, we also cannot rule out the possibility that these variants were originated by a RecA-independent recombination mechanism involving the MgPar sequences. Further analysis of these HA variants is warranted to more clearly elucidate the mechanisms involved.

Our observation that phase and antigenic variants accumulate in vitro, suggests that the mechanism triggering mgpB/C gene variation is stochastic and independent of selective pressure. However, we cannot rule out the possibility that gene variation could be enhanced by specific conditions. In this regard, we found that differences in the expression levels of recA have a direct impact on gene variation rates, indicating that gene diversity can potentially be enhanced. It is tempting to speculate that M. genitalium may be able to increase mgpB/C recombination in vivo by adjusting the RecA levels in response to the host environment. For instance, B. burgdorferi gene variation at the vlsE locus occurs exclusively in the mammalian host, suggesting the involvement of host factors in inducing or selecting variants in this microorganism (Zhang and Norris, 1998).

Another interesting observation from our study was the detection of three different RecA protein species in M. genitalium cell lysates. The possibility that these additional bands are the result of artifacts during protein electrophoresis or cell lysate preparation seems unlikely, because only one M. genitalium RecA specie is detected when expressed in E. coli. Thus, the generation of these RecA species may be dependent on the M. genitalium cell metabolism. Although further work is needed to confirm this view, the expression of these potential RecA isoforms could be explained by specific posttranslational cleavage events on the full length RecA protein. Alternatively, they may originate from additional translational start codons present in the recA coding sequence, which are recognized by the M. genitalium translational machinery. Supporting this hypothesis is the presence of two in frame triplets downstream from the proposed ATG start codon. These triplets are ATT and TTG, encoding residues I19 and L24, and may serve as alternative initiation codons (Golderer et al., 1995), resulting in predicted products with the observed molecular sizes. These hypotheses are currently being tested and work is in progress to determine the functional relevance of the expression of these putative isoforms.

Our studies also revealed notable differences between M. genitalium and the E. coli paradigm in DNA repair. We found that inactivation of recA in M. genitalium has no effect on cell survival after UV irradiation. Similarly, only a moderate but not significant reduction in cell viability was observed after DNA damage induced by MMC to the ΔrecA mutant. Such findings are in contrast to results obtained with E. coli as well as other species, in which recA mutants exhibit an exquisite sensitivity to these DNA-damaging treatments (Kuzminov, 1999). In E. coli, RecA performs two major functions in DNA repair: 1) it mediates homologous recombination, a process particularly important for restoring stalled replication forks and for repairing DSBs (Lusetti and Cox, 2002) and 2) it plays a key regulatory role inducing the SOS response (Kuzminov, 1999). In the presence of DNA damage, the co-protease activity of RecA becomes activated and triggers the autocatalytic cleavage of the LexA repressor, leading to the coordinated induction of different SOS genes, including recA and genes from the NER pathway. It is unknown whether M. genitalium RecA protein conserves this co-protease activity, but genome analysis does not reveal orthologs of the lexA gene. Despite the apparent lack of an SOS system, we found that M. genitalium is proficient in repairing photoproducts induced by UV irradiation, probably through the action of the NER pathway, as suggested by the high UV sensitivity exhibited by the ΔuvrC mutant. Although we cannot exclude the possibility that NER genes are induced through a RecA-independent mechanism, our results suggest that the basal expression level of the uvr genes is sufficient to guarantee the genome stability in M. genitalium. This hypothesis is favored by the extremely slow growth rate of this microorganism (~17 h). As previously suggested (Hanawalt, 1966), a reduced growth rate may allow the NER pathway sufficient time to repair DNA damage and prevent the formation of stalled replication forks without the need to induce a rapid SOS response. This scenario would minimize the requirement of the recombinational DNA repair pathway mediated by RecA. Consistent with this idea, it has been shown that in Mycoplasma pulmonis, which has a faster doubling time (~ 2 h) (Dybvig et al., 1989), a recA mutant is sensitive to UV irradiation (French et al., 2008).

Recombinational DNA repair is a complex pathway that requires, in addition to RecA, the action of multiple proteins (Kuzminov, 1999). Since M. genitalium apparently lacks many of these genes (Carvalho et al., 2005), it is also conceivable that recombinational DNA repair is not efficient in this organism. How M. genitalium deals with interstrand cross-links (ICLs) induced by MMC exposure is also unclear. The commonly accepted pathway to repair this severe damage is the combined action of NER and recombinational DNA repair, although an alternative mechanism involving NER and translation synthesis polymerases has also been suggested (Dronkert and Kanaar, 2001). The observation that the ΔuvrC mutant is sensitive to MMC reinforces the important role of NER in repairing MMC-induced DNA damage. However, the finding is different than that observed in E. coli, where a recombination-deficient, SOS-proficient recA142 mutant shows a similar sensitivity than an uvrB mutant and greater than a uvrC mutant (Vidal et al., 2006). One explanation for these differences could be that ICLs repair in M. genitalium is biased to the polymerase translation repair pathway. Alternatively, M. genitalium may be unable to efficiently repair ICLs, and the higher sensitivity observed in the ΔuvrC mutant is due to the action of NER repairing other MMC-induced DNA lesions different than ICLs (Dronkert and Kanaar, 2001).

Remarkably, in a study of saturating whole genome transposon mutagenesis, no transposon insertions were identified in uvrA, uvrB and uvrC, suggesting that the core components of the NER pathway are essential for growth in M. genitalium (Glass et al., 2006). Our successful deletion of the uvrC gene suggests that is not the case, at least for the uvrC endonuclease. Nevertheless, the growth defects observed in the ΔuvrC mutant and its severe DNA repair-deficient phenotype support the hypothesis that NER is the main DNA repair pathway to guarantee the genomic stability in M. genitalium.

In conclusion, to our knowledge, this study is the first report of the molecular requirements for mgpB/C phase and antigenic variation and provides fundamental insights on DNA repair in the context of a minimal genome. Studies are underway to investigate the role of other putative recombination enzymes in these processes, possible regulatory mechanisms for M. genitalium RecA expression, and the derivation and function of putative RecA isoforms.

Experimental procedures

Bacterial strains and growth conditions

Wild-type M. genitalium strain G37 (ATCC 33530) and its derivatives were grown in SP-4 broth (Tully et al., 1979) at 37°C under 5% CO2 in tissue culture flasks (Corning), unless otherwise indicated. SP-4 medium was supplemented with 0.8% agar (Difco) for colony development, and with chloramphenicol (15 μg ml−1), tetracycline (2 μg ml−1) or gentamicin (100 μg ml−1) during the selection of transformants. For the analysis of mgpB/C recombination we used a G37 single-colony filtered clone designated G37C, previously described elsewhere (Iverson-Cabral et al., 2007). The G37C strain is homogenous and contains mgpB/C sequences identical to those published for the G37 strain. E. coli strains TOP10 and BL21(DE3) (Invitrogen), used for cloning and protein overexpression, respectively, were grown at 37°C in LB broth or LB agar plates containing ampicillin (100 μg ml−1) and X-Gal (40 μg ml−1) as needed.

Construction of M. genitalium mutants and complementation experiments

General DNA manipulations were performed following standard procedures (Sambrook and Russell, 2001). All PCR products were obtained from genomic DNA of strain G37 using the primers summarized in Table S1.

To generate a recA null mutant, the suicide plasmid pΔMG_339 was engineered as follows. A 1,100 bp fragment spanning the 5′ flanking sequence of MG_339 gene was amplified with primers 5′RAKOmg339 and 3′RAKOmg339. Similarly, a 1,035 bp fragment from the 3′ flanking region was amplified with primers 5′LAKOmg339 and 3′LAKOmg339. We then amplified the chloramphenicol resistance gene (cat) under control of the Spiroplasma citri spiralin promoter (SpPr) (Lartigue et al., 2002) from a plasmid containing that antibiotic resistance gene expression cassette (sequence available from GenBank, accession number JX02666) using primers 5′cat-(SpPr) and 3′cat-(SpPr). The three PCR fragments generated overlapped each other by 50 bp and were joined by polymerase chain assembly (PCA) (Stemmer et al., 1995). The PCA product was amplified again using the terminal primers 5′LAKOmg339 and 3′RAKOmg339, and cloned into the pCR-Blunt II-Topo vector (Invitrogen).

To generate a null uvrC mutant the suicide plasmid pΔMG_206 was constructed as follows. A 981 bp PCR fragment spanning the 5′ flanking sequence of the MG_206 gene was amplified using primers 5′LAKOmg206 and 3′LAKOmg206, which incorporate Acc65I and EcoRIrestriction sites at their 5′ ends, respectively. A second 993 bp fragment containing the 3′ flanking sequence of the MG_206 gene was amplified using primers 5′RAKOmg206 and 3′RAKOmg206. These primers contained BamHI and XbaI restriction sites at their 5′ ends, respectively. Both PCR fragments were cloned into an EcoRV-digested pBE (Pich et al., 2006b), excised with the corresponding restriction enzymes, and ligated together with a 2-kb fragment containing the tetM438 selectable marker and an Acc65I/XbaI-digested pBSKII+ (Invitrogen). The tetM438 selectable marker was released from the pMTnTetM438 plasmid (Pich et al., 2006b) by digestion with EcoRI and BamHI.

For the complementation of the ΔrecA mutant, the mini-transposon plasmid pMTnTetM438-MG_339 containing a wild-type recA gene was constructed as follows. A fragment encompassing the first 219 bp upstream of the MG_339 gene, and its coding sequence was amplified with primers 3′mg339 and 5′mg339, which contain XhoI and EcoRI restriction sites at their 5′ ends, respectively. The PCR product was cloned into an EcoRV-digested pBE (Pich et al., 2006b), excised with the corresponding restriction enzymes, and cloned into a XhoI/EcoRI-digested pMTnTetM438 vector (Pich et al., 2006b).

For the complementation of the ΔuvrC mutant, the mini-transposon plasmid pMTnGm-MG_206 containing a wild-type uvrC gene was constructed as follows. A fragment encompassing the first 503 bp upstream of the MG_206 gene, and its coding sequence was amplified with primers 5′mg206 and 3′mg206, which contain XhoI and EcoRI restriction sites at their 5′ ends, respectively. The PCR product was cloned into an EcoRV-digested pBE (Pich et al., 2006b), excised with the corresponding restriction enzymes, and cloned into a XhoI/EcoRI-digested pMTnGm vector (Pich et al., 2006b).

Transformation of strain G37 was accomplished by electroporation as previously described (Pich et al., 2006b) with few modifications. Briefly, 30 μg of knock out construct DNA (pΔMG_339 or pΔMG_206) dissolved in 30 μl of electroporation buffer (8 mM HEPES pH 7.2, 272 mM sucrose) was mixed with 90 μl of cells (approximately 109 cells ml−1) also resuspended in electroporation buffer. The mixture was transferred to a 2 mm gapped electroporation cuvette (Bio-Rad), kept on ice for 15 min and electroporated using the Gene PulserR II electroporation system (Bio-Rad) with the Pulse Controller set at 2.5 kV and 100 Ω. The cuvette was placed on ice for 15 min and then 900 μl of SP-4 medium was added. After 3 h of incubation at 37°C, transformants were selected onto SP-4 plates containing the appropriate antibiotic. After 2 weeks of incubation at 37°C and 5% CO2, single colonies were picked, propagated in 5 ml of SP-4 containing the appropriate antibiotic and stored at −80°C. The intended genetic modifications were then confirmed by PCR using selected primers (Fig. 1 and Fig. 6) and Southern blot analyses (Fig. S1). Complementation of the resulting null mutants was achieved via transposition, by electroporating 5 μg of pMTnTetM438-MG_339 or pMTnGm-MG_206 plasmids into the ΔrecA or ΔuvrC mutants, respectively, using similar techniques as described above. The insertion of a single transposon in the genome of the ΔrecA and ΔuvrC complemented strains was confirmed by Southern blot analysis (Fig. S4). The specific insertion sites were further determined by sequencing the flanking genomic DNA with 5′ Tc_seq and 3′ Tn_seq primers, respectively (Table S1, Fig. S4).

Expression and purification of M. genitalium RecA and antibody production

The MG_339 coding sequence was amplified from genomic DNA of strain G37 using primers 5′ExpRecA and 3′ExpRecA, which contain XhoI and NcoI restriction sites at their 5′ ends, respectively. The resulting PCR product was cloned into an EcoRV-digested pBE (Pich et al., 2006b), excised with the corresponding restriction enzymes, cloned into a XhoI/NcoI-digested pET21-d expression vector (Novagen) and transformed into E. coli BL21(DE3). Transformant cells were grown in 400 ml LB broth at 37°C to an optical density at 600 nm of 0.6. After 3 h of induction with 1 mM IPTG, cells were harvested, re-suspended in 20 ml binding buffer [5 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9], lysed by sonication in the presence of 1 mM PMSF and clarified by centrifugation. The supernatant was filtered through a 0.45 μm filter and applied to a column containing Ni-NTA-Agarose (Qiagen) pre-equilibrated with binding buffer. The column was washed with 60 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9 and proteins were eluted in 1 M imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9. The eluted fraction was dialyzed against 2 liters of PBS and purity was estimated by SDS-PAGE and Coomassie blue staining to be > 95% (Fig. S2A).

Polyclonal antisera against M. genitalium RecA was commercially produced by immunization of rabbits with the purified recombinant RecA protein (Pacific Immunology Corp., CA). Antibody specificity was further assessed by immunoblot using E. coli and M. genitalium cell extracts expressing His-tagged and non-tagged M. genitalium RecA variants (Fig S2C–D).

Immunoblot analyses

Cell extracts were subjected to electrophoresis through a 12% SDS-polyacrylamide gel, transferred electrophoretically to a nitrocellulose membrane (Protran BA 85) and probed for 2 h at room temperature with a 1:1000 dilution of rabbit anti-M. genitalium RecA antibodies, following standard procedures (Sambrook and Russell, 2001). Goat anti-rabbit IgG conjugated to alkaline phosphatase (Sigma) was used as secondary antibody. Antigen-antibody complexes were visualized using nitroblue tetrazolium (Bio-Rad) and 5-bromo-4-chloro-3-indolyl-phosphate (Roche) reagents according to the supplier’s instructions.

Assessment of growth rates

Growth curves were obtained by monitoring the number of genomes over time by real-time quantitative PCR (qPCR). To do so, the M. genitalium G37 and mutant strains were grown in 20 ml of SP-4 broth in 50 ml conical tubes (Corning) for 10 days at 37°C under 5% CO2. The screw caps of the tubes were loosened to permit gas exchange. Cultures grown to a similar density of approximately 1 × 108 cfu ml−1 were used as inoculum for each strain. The qPCR confirmed that a similar number of bacterial cell equivalents were inoculated. Aliquots of 0.5 ml were taken every 48 h from each culture, centrifuged at 20,000 × g for 15 min and the resulting pellets were maintained at −20°C until needed. DNA extraction from each sample was performed using the MasterPure DNA purification kit (Epicenter) according to the manufacture’s instructions. The number of genomes in each sample was quantified by real-time PCR as described below for the mgpB/C gene variation assay.

mgpB/C gene variation assay

To monitor gene variation over time, G37C, ΔrecA and ΔrecA+recA strains were propagated as follows. Five milliliters of SP-4 were inoculated and cultivated for 5 days (7 generations). Cells were scraped off from the flasks in the same culture media, thereby harvesting both adherent and non-adherent cells. One milliliter from this 5 ml cell suspension was taken and centrifuged, and the pellet was stored at −20°C for further DNA extraction. Another 1 ml was kept as a frozen stock at −80°C for the hemadsorption assay (see below). Twenty-five μl of culture was then used to inoculate the next culture and the process was repeated for ten passages. Each passage was performed in duplicate.

A real-time qPCR-based assay was used to determine the frequency of mgpB/C variants in each passage. Based on the genome sequence of G37 strain (GenBank accession number NC_000908), we designed four different anchored PCR assays designated B-24, EF-2478, G-135 and KLM-7, with letters and numbers indicating respectively, the variable region within mgpB or mgpC genes and the MgPar sites targeted (eg. B-24 targets recombinants between region B and MgPar sites 2 or 4). These anchored PCR assays detect specific variants in which the MgPar sequences targeted by the primers have translocated into the MgpB/C expression site. The set of primers used for each PCR assay are listed in Table S1. To normalize the number of variants to the number of genomes in each sample, we used a second qPCR targeting the 16S ribosomal RNA gene which is present in a single copy by using primers 5′RT16SrRNA and 3′ RT16SrRNA (Table S1). Real-time qPCR was performed in a LightCycler instrument (Roche), using the LightCycler-FastStart DNA Master SYBR Green I Kit (Roche). PCR reactions were performed in a final volume of 20 μl containing 2 μl of DNA (approximately 1 × 107 genomes), 0.5 μM of each primer and 2 μl 10x SYBR Green mix. The MgCl2 concentration was optimized for all reactions at 3 mM, except for KLM-7 and G-135 qPCRs, which required 4.5 and 4 mM, respectively. After an initial 10 min incubation at 95°C, each qPCR assay was performed using the following amplification conditions: (1) KLM-7: 40 cycles of 95°C for 10 s, 52°C for 10 s, and 72°C for 18 s, (2) B-24 and G-135: 40 cycles of 95°C for 10 s, 56°C for 10 s, and 72°C for 16 s, (3) 16SrRNA and EF-2478: 40 cycles of 95°C for 10 s, 54°C for 10 s, and 72°C for 10 s. Fluorescence readings were acquired at 79°C for KLM-7 and 77°C for the other qPCR assays. Each set of primers generated amplification reactions with efficiencies ranging from 90 to 100%. Specificity of PCR products was verified by melting curve analysis and agarose gel electrophoresis. PCR products were also cloned into an EcoRV-digested pBE (Pich et al., 2006b) and the expected sequence from 5 clones for each anchored PCR was confirmed by sequencing. Absolute quantification was performed by creating standard curves using ScaI-linerarized pBE (Pich et al., 2006b) plasmids harboring the PCR product. The plasmid copy number was determined spectrophotometricallyusing a ND-1000 spectrophotometer (NanoDrop Technologies). The qPCR reactions were performed in duplicate and output data was analyzed by using the LightCycler 3.5 software (Roche).

RNA isolation and quantitative reverse transcriptase PCR (qRT-PCR)

Total RNA was extracted from 20 ml of mid-logarithmic phase cultures using the RNAaqueous Kit (Ambion) following the manufacturer’s instructions. One μg of DNAse-treated RNA (TURBO DNAse, Ambion) was reverse transcribed by using the SuperScript III First-Strand synthesis kit (Invitrogen) with random hexamers according to the manufacturer’s instructions. Parallel reactions were performed with no reverse transcriptase to control for contaminating DNA. Real-time qPCR analysis of the resulting cDNAs was performed in duplicate as described for the mgpB/C gene variation assay using 2 μl of >1:10 diluted cDNA. Primers used for amplification of MG_339 transcripts were 5′RTMG_339 and 3′RTMG_339 (Table S1). PCR conditions were the same as those used for the reference gene (16S ribosomal RNA), which were previously described in the mgpB/C gene variation assay (see above). Arbitrary quantification of target and reference genes was determined from standard curves generated by 5 serial dilutions of the cDNA. The relative abundance of MG_339 transcripts for each sample was then normalized to the 16S ribosomal RNA.

Hemadsorption (HA) assay

G37C, ΔrecA and ΔrecA+recA strains were serially passaged as described above for the mgpB/C gene variation assay. Serial dilutions of cells from the first and tenth passage were grown on SP-4 plates and the resulting colonies were tested for their capacity to adsorb sheep erythrocytes (Remel) as previously described (Pich et al., 2006a). Colonies were visualized by light microscopy and the frequency of spontaneous HA deficient variants was calculated by dividing the number of colonies that failed to adsorb erythrocytes by the total number of colonies analyzed. Approximately 3000 colonies per passage were analyzed for G37C and ΔrecA+recA strains, whereas ~15,000 colonies were examined for the ΔrecA mutant.

UV and mitomycin C sensitivity assays

M. genitalium G37 and mutant strains were grown to exponential-phase in 20 ml of SP-4 broth. For the UV sensitivity assay, cells were washed three times in phosphate-buffered saline (PBS), scraped off the tissue culture flasks and diluted in 10 ml PBS to obtain approximately 1 × 108 cfu ml−1. One milliliter of this cell suspension was then dispensed into several 35 × 10 mm culture dishes, which were separately exposed to increasing doses of UV radiation using a CL-1000 Ultraviolet Crosslinker (UVP). After UV exposure, cells were serially diluted and 10 μl of each dilution was spotted in duplicate onto SP-4 plates. Although no photolyase enzymes have been identified in M. genitalium, light was minimized during the whole procedure. After incubation for 14 days, colonies were counted and survival rates were calculated as compared to un-treated samples.

For the mitomycin C (MMC) sensitivity assay, cells were scraped off the tissue culture flasks, suspended in SP-4 broth and aliquoted into tubes containing serial two 2-fold dilutions of MMC (Sigma). After 24 h of MMC exposure at 37°C under 5% CO2, serial dilutions of each treatment were plated in duplicate onto SP-4 plates and survival rates were analyzed as described above for the UV sensitivity assay.

Supplementary Material

Supp Fig S1-S4 & Table S1

Acknowledgments

This work was supported by NIH grant R56 AI071175 ARRA to P.A.T and the U.S. Department of Energy Cooperative Agreement No. DE-FC02-02ER63453 at the J. Craig Venter Institute. We thank Nacyra Assad-Garcia and Carole Lartigue for assistance making the ΔrecA mutant and Stefanie Iverson-Cabral for helpful discussions and critical reading of the manuscript.

References

  • Algire MA, Lartigue C, Thomas DW, Assad-Garcia N, Glass JI, Merryman C. New selectable marker for manipulating the simple genomes of Mycoplasma species. Antimicrob Agents Chemother. 2009;53:4429–4432. [PMC free article] [PubMed]
  • Burgos R, Pich OQ, Ferrer-Navarro M, Baseman JB, Querol E, Pinol J. Mycoplasma genitalium P140 and P110 cytadhesins are reciprocally stabilized and required for cell adhesion and terminal-organelle development. J Bacteriol. 2006;188:8627–8637. [PMC free article] [PubMed]
  • Burgos R, Pich OQ, Querol E, Pinol J. Functional analysis of the Mycoplasma genitalium MG312 protein reveals a specific requirement of the MG312 N-terminal domain for gliding motility. J Bacteriol. 2007;189:7014–7023. [PMC free article] [PubMed]
  • Carvalho FM, Fonseca MM, Batistuzzo De Medeiros S, Scortecci KC, Blaha CA, Agnez-Lima LF. DNA repair in reduced genome: the Mycoplasma model. Gene. 2005;360:111–119. [PubMed]
  • Citti C, Nouvel LX, Baranowski E. Phase and antigenic variation in mycoplasmas. Future Microbiol. 2010;5:1073–1085. [PubMed]
  • Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK, Sinei SK, Bwayo JJ, Totten PA. Association between Mycoplasma genitalium and acute endometritis. Lancet. 2002;359:765–766. [PubMed]
  • Cohen CR, Nosek M, Meier A, Astete SG, Iverson-Cabral S, Mugo NR, Totten PA. Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis. 2007;34:274–279. [PubMed]
  • Criss AK, Kline KA, Seifert HS. The frequency and rate of pilin antigenic variation in Neisseria gonorrhoeae. Mol Microbiol. 2005;58:510–519. [PMC free article] [PubMed]
  • Dresser AR, Hardy PO, Chaconas G. Investigation of the genes involved in antigenic switching at the vlsE locus in Borrelia burgdorferi: an essential role for the RuvAB branch migrase. PLoS Pathog. 2009;5:e1000680. [PMC free article] [PubMed]
  • Dronkert ML, Kanaar R. Repair of DNA interstrand cross-links. Mutat Res. 2001;486:217–247. [PubMed]
  • Dutra BE, Sutera VA, Jr, Lovett ST. RecA-independent recombination is efficient but limited by exonucleases. Proc Natl Acad Sci U S A. 2007;104:216–221. [PubMed]
  • Dybvig K, Simecka JW, Watson HL, Cassell GH. High-frequency variation in Mycoplasma pulmonis colony size. J Bacteriol. 1989;171:5165–5168. [PMC free article] [PubMed]
  • Estevao S, Sluijter M, Hartwig NG, van Rossum AM, Vink C. Functional characterization of the RuvB homologs from Mycoplasma pneumoniae and Mycoplasma genitalium. J Bacteriol. 2011;193:6425–6435. [PMC free article] [PubMed]
  • Fraser CM, Gocayne JD, White O, Adams MD, Clayton RA, Fleischmann RD, Bult CJ, Kerlavage AR, Sutton G, Kelley JM, Fritchman RD, Weidman JF, Small KV, Sandusky M, Fuhrmann J, Nguyen D, Utterback TR, Saudek DM, Phillips CA, Merrick JM, Tomb JF, Dougherty BA, Bott KF, Hu PC, Lucier TS, Peterson SN, Smith HO, Hutchison CA, 3rd, Venter JC. The minimal gene complement of Mycoplasma genitalium. Science. 1995;270:397–403. [PubMed]
  • French CT, Lao P, Loraine AE, Matthews BT, Yu H, Dybvig K. Large-scale transposon mutagenesis of Mycoplasma pulmonis. Mol Microbiol. 2008;69:67–76. [PMC free article] [PubMed]
  • Glass JI, Assad-Garcia N, Alperovich N, Yooseph S, Lewis MR, Maruf M, Hutchison CA, 3rd, Smith HO, Venter JC. Essential genes of a minimal bacterium. Proc Natl Acad Sci U S A. 2006;103:425–430. [PubMed]
  • Golderer G, Dlaska M, Grobner P, Piendl W. TTG serves as an initiation codon for the ribosomal protein MvaS7 from the archaeon Methanococcus vannielii. J Bacteriol. 1995;177:5994–5996. [PMC free article] [PubMed]
  • Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis. 2008;21:65–69. [PubMed]
  • Hanawalt PC. The U.V. sensitivity of bacteria: its relation to the DNA replication cycle. Photochem Photobiol. 1966;5:1–12. [PubMed]
  • Helm RA, Seifert HS. Frequency and rate of pilin antigenic variation of Neisseria meningitidis. J Bacteriol. 2010;192:3822–3823. [PMC free article] [PubMed]
  • Henderson IR, Owen P, Nataro JP. Molecular switches--the ON and OFF of bacterial phase variation. Mol Microbiol. 1999;33:919–932. [PubMed]
  • Iverson-Cabral SL, Astete SG, Cohen CR, Rocha EP, Totten PA. Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences. Infect Immun. 2006;74:3715–3726. [PMC free article] [PubMed]
  • Iverson-Cabral SL, Astete SG, Cohen CR, Totten PA. mgpB and mgpC sequence diversity in Mycoplasma genitalium is generated by segmental reciprocal recombination with repetitive chromosomal sequences. Mol Microbiol. 2007;66:55–73. [PubMed]
  • Iverson-Cabral SL, Manhart LE, Totten PA. Detection of Mycoplasma genitalium-reactive cervicovaginal antibodies among infected women. Clin Vaccine Immunol. 2011;18:1783–1786. [PMC free article] [PubMed]
  • Jensen JS. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol. 2004;18:1–11. [PubMed]
  • Koomey M, Gotschlich EC, Robbins K, Bergstrom S, Swanson J. Effects of recA mutations on pilus antigenic variation and phase transitions in Neisseria gonorrhoeae. Genetics. 1987;117:391–398. [PubMed]
  • Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM. Biochemistry of homologous recombination in Escherichia coli. Microbiol Rev. 1994;58:401–465. [PMC free article] [PubMed]
  • Krause DC, Balish MF. Cellular engineering in a minimal microbe: structure and assembly of the terminal organelle of Mycoplasma pneumoniae. Mol Microbiol. 2004;51:917–924. [PubMed]
  • Kuzminov A. Recombinational repair of DNA damage in Escherichia coli and bacteriophage lambda. Microbiol Mol Biol Rev. 1999;63:751–813. [PMC free article] [PubMed]
  • Lartigue C, Duret S, Garnier M, Renaudin J. New plasmid vectors for specific gene targeting in Spiroplasma citri. Plasmid. 2002;48:149–159. [PubMed]
  • Lin T, Gao L, Edmondson DG, Jacobs MB, Philipp MT, Norris SJ. Central role of the Holliday junction helicase RuvAB in vlsE recombination and infectivity of Borrelia burgdorferi. PLoS Pathog. 2009;5:e1000679. [PMC free article] [PubMed]
  • Liveris D, Mulay V, Sandigursky S, Schwartz I. Borrelia burgdorferi vlsE antigenic variation is not mediated by RecA. Infect Immun. 2008;76:4009–4018. [PMC free article] [PubMed]
  • Lluch-Senar M, Querol E, Pinol J. Cell division in a minimal bacterium in the absence of ftsZ. Mol Microbiol. 2010;78:278–289. [PubMed]
  • Lusetti SL, Cox MM. The bacterial RecA protein and the recombinational DNA repair of stalled replication forks. Annu Rev Biochem. 2002;71:71–100. [PubMed]
  • Ma L, Jensen JS, Myers L, Burnett J, Welch M, Jia Q, Martin DH. Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome. Mol Microbiol. 2007;66:220–236. [PMC free article] [PubMed]
  • Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, Totten PA. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis. 2003;187:650–657. [PubMed]
  • McCulloch R, Barry JD. A role for RAD51 and homologous recombination in Trypanosoma brucei antigenic variation. Genes Dev. 1999;13:2875–2888. [PubMed]
  • Mernaugh GR, Dallo SF, Holt SC, Baseman JB. Properties of adhering and nonadhering populations of Mycoplasma genitalium. Clin Infect Dis. 1993;17(Suppl 1):S69–78. [PubMed]
  • Paabo S, Higuchi RG, Wilson AC. Ancient DNA and the polymerase chain reaction. The emerging field of molecular archaeology. J Biol Chem. 1989;264:9709–9712. [PubMed]
  • Peterson SN, Bailey CC, Jensen JS, Borre MB, King ES, Bott KF, Hutchison CA., 3rd Characterization of repetitive DNA in the Mycoplasma genitalium genome: possible role in the generation of antigenic variation. Proc Natl Acad Sci U S A. 1995;92:11829–11833. [PubMed]
  • Pich OQ, Burgos R, Ferrer-Navarro M, Querol E, Pinol J. Mycoplasma genitalium mg200 and mg386 genes are involved in gliding motility but not in cytadherence. Mol Microbiol. 2006a;60:1509–1519. [PubMed]
  • Pich OQ, Burgos R, Planell R, Querol E, Pinol J. Comparative analysis of antibiotic resistance gene markers in Mycoplasma genitalium: application to studies of the minimal gene complement. Microbiology. 2006b;152:519–527. [PubMed]
  • Rocha EP, Cornet E, Michel B. Comparative and evolutionary analysis of the bacterial homologous recombination systems. PLoS Genet. 2005;1:e15. [PMC free article] [PubMed]
  • Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 2001.
  • Sciochetti SA, Blakely GW, Piggot PJ. Growth phase variation in cell and nucleoid morphology in a Bacillus subtilis recA mutant. J Bacteriol. 2001;183:2963–2968. [PMC free article] [PubMed]
  • Sluijter M, Spuesens EB, Hartwig NG, van Rossum AM, Vink C. The Mycoplasma pneumoniae MPN490 and Mycoplasma genitalium MG339 genes encode RecA homologs that promote homologous DNA strand exchange. Infect Immun. 2009;77:4905–4911. [PMC free article] [PubMed]
  • Sluijter M, Kaptein E, Spuesens EB, Hoogenboezem T, Hartwig NG, Van Rossum AM, Vink C. The Mycoplasma genitalium MG352-encoded protein is a Holliday junction resolvase that has a non-functional orthologue in Mycoplasma pneumoniae. Mol Microbiol. 2010;77:1261–1277. [PubMed]
  • Stemmer WP, Crameri A, Ha KD, Brennan TM, Heyneker HL. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene. 1995;164:49–53. [PubMed]
  • Svenstrup HF, Jensen JS, Gevaert K, Birkelund S, Christiansen G. Identification and characterization of immunogenic proteins of Mycoplasma genitalium. Clin Vaccine Immunol. 2006;13:913–922. [PMC free article] [PubMed]
  • Tully JG, Rose DL, Whitcomb RF, Wenzel RP. Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly-modified culture medium. J Infect Dis. 1979;139:478–482. [PubMed]
  • Turner CM, Barry JD. High frequency of antigenic variation in Trypanosoma brucei rhodesiense infections. Parasitology. 1989;99(Pt 1):67–75. [PubMed]
  • Turner CM. The rate of antigenic variation in fly-transmitted and syringe-passaged infections of Trypanosoma brucei. FEMS Microbiol Lett. 1997;153:227–231. [PubMed]
  • van der Woude MW, Baumler AJ. Phase and antigenic variation in bacteria. Clin Microbiol Rev. 2004;17:581–611. [PMC free article] [PubMed]
  • Van Houten B, Croteau DL, DellaVecchia MJ, Wang H, Kisker C. ‘Close-fitting sleeves’: DNA damage recognition by the UvrABC nuclease system. Mutat Res. 2005;577:92–117. [PubMed]
  • Vidal LS, Santos LB, Lage C, Leitao AC. Enhanced sensitivity of Escherichia coli uvrB mutants to mitomycin C points to a UV-C distinct repair for DNA adducts. Chem Res Toxicol. 2006;19:1351–1356. [PubMed]
  • Vink C, Rudenko G, Seifert HS. Microbial antigenic variation mediated by homologous DNA recombination. FEMS Microbiol Rev 2011 [PMC free article] [PubMed]
  • Zhang JR, Norris SJ. Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun. 1998;66:3689–3697. [PMC free article] [PubMed]